The Valley Desk

ArticleRheumatology and therapyPublished

On-Label Treatment Persistence Through 24 Months Among Patients with Active Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Tumor Necrosis Factor Inhibitors

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, with Drexel University linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Rheumatology and therapy
Published
Subject terms
Psoriatic Arthritis; Treatment Persistence; Guselkumab; Biologic-naïve; Biologic-experienced; Subcutaneous Tumor Necrosis Factor Inhibitor
PubMed ID
41239039
PubMed Central ID
PMC12816468
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal